explore -WSS

explore

author：leisure time 2025-10-01 11:45:07 - browse：53464

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LEXINGTON, Mass. — New obesity drugs like Wegovy and Zepbound are currently taken once a week, indefinitely. But what if they could be taken once a year instead, like a vaccine?

That’s a question that Novo Nordisk, the pharma company behind Wegovy, is exploring as it faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday. “Could we think about vaccine-like properties, where imagine you had, once a year, an injection with an equivalent of a GLP-1 that really helps you to maintain weight loss and have cardiovascular benefits?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Global cancer cases to surge 77% by 2050, WHO report says

WSS

A new approach to psychiatric drug development

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Updated Covid vaccine has 54% effectiveness, new study suggests

Microsoft's Peter Lee: Generative AI could help doctors be more human

Stem cell biologist probes earliest stages of human development

340B reform proposal comes out of Senate working group

entertainment

explore

knowledge

The high cost of giving birth even with insurance

Devoted Health’s losses in Medicare Advantage persist

The cancer drug shortage isn’t new — and neither are the solutions

Why Talkspace is targeting Medicare, a tricky market

Heart attack and stroke risk calculators need revising

Adopting new red light myopia treatments may be short

Trump demands the U.S. pay no more for drugs than other countries … again

Surgery pushed Ben Carson to fame

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Texas Medical Board asked to define abortion emergency exception

hotspot

Pregnant women don't need prenatal multivitamins, study concludes

The Biogen Aduhelm mess could happen again

Updated Covid vaccine has 54% effectiveness, new study suggests

Padmanee Sharma of MD Anderson at center of lawsuit over credit

For AI in health care standards, federal regulators join with industry group

$1 billion proposal to grow Boston, Massachusetts biotech

entertainment

hotspot

explore

hotspot